Found: 15
Select item for more details and to access through your institution.
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall Survival.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1068, doi. 10.3390/cells12071068
- By:
- Publication type:
- Article
Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 76, doi. 10.1007/s10120-013-0236-z
- By:
- Publication type:
- Article
Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 2, p. 233, doi. 10.1007/s10120-012-0171-4
- By:
- Publication type:
- Article
Emerging and Experimental Agents for Anal Cancer: What is New?
- Published in:
- Journal of Experimental Pharmacology, 2021, v. 13, p. 433, doi. 10.2147/JEP.S262342
- By:
- Publication type:
- Article
Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10082029
- By:
- Publication type:
- Article
Outpatient Palliative Care Program: Impact on Home Death Rate in Brazil.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1380, doi. 10.3390/cancers16071380
- By:
- Publication type:
- Article
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 679, doi. 10.3390/cancers16030679
- By:
- Publication type:
- Article
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5015, doi. 10.3390/cancers15205015
- By:
- Publication type:
- Article
The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 8, p. 1073, doi. 10.1007/s11864-022-00939-3
- By:
- Publication type:
- Article
Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2136128, doi. 10.1001/jamanetworkopen.2021.36128
- By:
- Publication type:
- Article